150 related articles for article (PubMed ID: 32599532)
1. AGL2017-82570-RReverse genetics approaches for the development of new vaccines against influenza A virus infections.
Martinez-Sobrido L; DeDiego ML; Nogales A
Curr Opin Virol; 2020 Oct; 44():26-34. PubMed ID: 32599532
[TBL] [Abstract][Full Text] [Related]
2. Reverse Genetics Approaches for the Development of Influenza Vaccines.
Nogales A; Martínez-Sobrido L
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025504
[TBL] [Abstract][Full Text] [Related]
3. Taming influenza viruses.
Ozawa M; Kawaoka Y
Virus Res; 2011 Dec; 162(1-2):8-11. PubMed ID: 21968297
[TBL] [Abstract][Full Text] [Related]
4. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
[TBL] [Abstract][Full Text] [Related]
5. All-in-one bacmids: an efficient reverse genetics strategy for influenza A virus vaccines.
Chen H; Angel M; Li W; Finch C; Gonzalez AS; Sutton T; Santos J; Perez DR
J Virol; 2014 Sep; 88(17):10013-25. PubMed ID: 24942589
[TBL] [Abstract][Full Text] [Related]
6. Plasmid-Based Reverse Genetics of Influenza A Virus.
Perez DR; Angel M; Gonzalez-Reiche AS; Santos J; Obadan A; Martinez-Sobrido L
Methods Mol Biol; 2017; 1602():251-273. PubMed ID: 28508225
[TBL] [Abstract][Full Text] [Related]
7. Plasmid-Based Reverse Genetics of Influenza A Virus.
Perez DR; Seibert B; Ferreri L; Lee CW; Rajao D
Methods Mol Biol; 2020; 2123():37-59. PubMed ID: 32170679
[TBL] [Abstract][Full Text] [Related]
8. Analysis of different DNA vaccines for protection of experimental influenza A virus infection.
Wiesener N; Schütze T; Lapp S; Lehmann M; Jarasch-Althof N; Wutzler P; Henke A
Viral Immunol; 2011 Aug; 24(4):321-30. PubMed ID: 21830903
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a Reverse Genetics System for Influenza D Virus.
Ishida H; Murakami S; Kamiki H; Matsugo H; Takenaka-Uema A; Horimoto T
J Virol; 2020 May; 94(10):. PubMed ID: 32102883
[TBL] [Abstract][Full Text] [Related]
10. Influenza A Virus Subpopulations and Their Implication in Pathogenesis and Vaccine Development.
Ghorbani A; Ngunjiri JM; Lee CW
Annu Rev Anim Biosci; 2020 Feb; 8():247-267. PubMed ID: 31479617
[TBL] [Abstract][Full Text] [Related]
11. [Preclinical studies of live intranasal H5N1 influenza vaccine with the deleted HS1 gene].
Romanovskaia-Roman'ko EA; Ferko B; Vyshemirskiĭ OI; Romanova IuR; Krenn B; Muster T; Grudinin MP; Lapin BA; Egorov AIu; Kiselev OI
Vopr Virusol; 2011; 56(6):19-22. PubMed ID: 22359944
[TBL] [Abstract][Full Text] [Related]
12. Pathological and immunological protection induced by inactivated reverse genetics-based H3N8 equine influenza vaccine candidate in murine model.
Kumar R; Gupta RP; Bera BC; Anand T; Bhatia S; Kumar N; Sood R; Pavulraj S; Mathew MK; Balena V; Karthik S; Sansanwal R; Tripathi BN; Virmani N
Acta Virol; 2020; 64(3):359-374. PubMed ID: 32985215
[TBL] [Abstract][Full Text] [Related]
13. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
[TBL] [Abstract][Full Text] [Related]
14. Development of an Alternative Modified Live Influenza B Virus Vaccine.
Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
[TBL] [Abstract][Full Text] [Related]
15. Reverse Genetics of Influenza B Viruses.
Nogales A; Perez DR; Santos J; Finch C; Martínez-Sobrido L
Methods Mol Biol; 2017; 1602():205-238. PubMed ID: 28508223
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
[TBL] [Abstract][Full Text] [Related]
17. Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines.
Wang P; Zheng M; Lau SY; Chen P; Mok BW; Liu S; Liu H; Huang X; Cremin CJ; Song W; Chen Y; Wong YC; Huang H; To KK; Chen Z; Xia N; Yuen KY; Chen H
mBio; 2019 Sep; 10(5):. PubMed ID: 31530680
[TBL] [Abstract][Full Text] [Related]
18. Influenza reverse genetics: dissecting immunity and pathogenesis.
Ye S; Evans JG; Stambas J
Expert Rev Mol Med; 2014 Feb; 16():e2. PubMed ID: 24528628
[TBL] [Abstract][Full Text] [Related]
19. Rationally Designed Influenza Virus Vaccines That Are Antigenically Stable during Growth in Eggs.
Harding AT; Heaton BE; Dumm RE; Heaton NS
mBio; 2017 Jun; 8(3):. PubMed ID: 28588131
[TBL] [Abstract][Full Text] [Related]
20. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
